← FDA DRUG APPROVALS

FDA ANDA · ANDA087007

TRICHLORMETHIAZIDE

Sponsor: PAR PHARM

APPLICATION
ANDA087007
TYPE
ANDA
ORIGINAL APPROVAL
1981-02-06
LATEST ACTION
1991-06-25
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

TRICHLORMETHIAZIDEDiscontinued
TRICHLORMETHIAZIDE 2MG · TABLET · ORAL

Approval history

1991-06-25Labeling · Supplement 12AP
1989-07-31Labeling · Supplement 11AP
1989-07-11Labeling · Supplement 10AP
1989-02-03Manufacturing (CMC) · Supplement 9AP
1986-08-14Manufacturing (CMC) · Supplement 4AP
1986-08-14Manufacturing (CMC) · Supplement 2AP
1981-02-06OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →